HEADER TRANSCRIPTION 12-FEB-09 3G8O TITLE PROGESTERONE RECEPTOR WITH BOUND PYRROLIDINE 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGESTERONE RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C3, PGR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHIS GST KEYWDS PROGESTERONE RECEPTOR, STEROID HORMONE RECEPTOR, NUCLEAR RECEPTOR, KEYWDS 2 PR, PROGESTERONE, ALPHA HELICAL SANDWICH, DNA-BINDING, LIPID- KEYWDS 3 BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, RECEPTOR, STEROID- KEYWDS 4 BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR S.K.THOMPSON,D.G.WASHBURN,K.P.MADAUSS,S.P.WILLIAMS,E.L.STEWART REVDAT 4 06-SEP-23 3G8O 1 REMARK SEQADV REVDAT 3 01-NOV-17 3G8O 1 REMARK REVDAT 2 11-APR-12 3G8O 1 SPRSDE TITLE REMARK VERSN REVDAT 1 16-FEB-10 3G8O 0 SPRSDE 11-APR-12 3G8O 3G8N JRNL AUTH S.K.THOMPSON,D.G.WASHBURN,J.S.FRAZEE,K.P.MADAUSS,T.H.HOANG, JRNL AUTH 2 L.LAPINSKI,E.T.GRYGIELKO,L.E.GLACE,W.TRIZNA,S.P.WILLIAMS, JRNL AUTH 3 C.DURAISWAMI,J.D.BRAY,N.J.LAPING JRNL TITL RATIONAL DESIGN OF ORALLY-ACTIVE, PYRROLIDINE-BASED JRNL TITL 2 PROGESTERONE RECEPTOR PARTIAL AGONISTS. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 4777 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19595590 JRNL DOI 10.1016/J.BMCL.2009.06.055 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 38617 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.600 REMARK 3 FREE R VALUE TEST SET COUNT : 2688 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3976 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 55 REMARK 3 SOLVENT ATOMS : 352 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.22400 REMARK 3 B22 (A**2) : -0.12700 REMARK 3 B33 (A**2) : -0.09700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.00900 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : 309.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3G8O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1000051562. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : QUANTUM 210 REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38672 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.2430 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.42100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1A28 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 0.2M LITHIUM SULFATE, 15% REMARK 280 PEG3350, PH 7.0, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.10400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 671 REMARK 465 SER A 672 REMARK 465 PHE A 673 REMARK 465 THR A 674 REMARK 465 PHE A 675 REMARK 465 SER A 676 REMARK 465 PRO A 677 REMARK 465 GLY A 678 REMARK 465 GLN A 679 REMARK 465 ASP A 680 REMARK 465 ILE A 681 REMARK 465 PRO A 708 REMARK 465 LYS A 933 REMARK 465 GLY B 671 REMARK 465 SER B 672 REMARK 465 PHE B 673 REMARK 465 THR B 674 REMARK 465 PHE B 675 REMARK 465 SER B 676 REMARK 465 PRO B 677 REMARK 465 GLY B 678 REMARK 465 GLN B 679 REMARK 465 ASP B 680 REMARK 465 ILE B 681 REMARK 465 GLN B 682 REMARK 465 LYS B 933 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 682 CG CD OE1 NE2 REMARK 470 LEU A 683 CG CD1 CD2 REMARK 470 LYS A 707 CG CD CE NZ REMARK 470 ASP A 709 CG OD1 OD2 REMARK 470 ARG A 859 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 860 CG CD OE1 NE2 REMARK 470 LYS A 861 CG CD CE NZ REMARK 470 GLN A 868 CG CD OE1 NE2 REMARK 470 ARG A 899 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 904 CG CD OE1 OE2 REMARK 470 LYS A 932 CG CD CE NZ REMARK 470 LEU B 683 CG CD1 CD2 REMARK 470 LYS B 790 CG CD CE NZ REMARK 470 GLN B 812 CG CD OE1 NE2 REMARK 470 ARG B 859 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 861 CG CD CE NZ REMARK 470 GLN B 868 CG CD OE1 NE2 REMARK 470 ASP B 882 CG OD1 OD2 REMARK 470 LYS B 932 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 706 -72.76 -74.53 REMARK 500 LEU A 782 81.26 -150.63 REMARK 500 SER A 837 49.87 -99.72 REMARK 500 GLN A 860 86.91 -67.51 REMARK 500 MET A 924 35.07 -90.26 REMARK 500 SER B 772 24.31 49.15 REMARK 500 SER B 837 47.54 -101.69 REMARK 500 ARG B 859 -42.09 -131.00 REMARK 500 MET B 924 43.11 -94.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 30X A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 30X B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HQ5 RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR WITH BOUND PYRROLIDINE 22 DBREF 3G8O A 673 933 UNP P06401 PRGR_HUMAN 673 933 DBREF 3G8O B 673 933 UNP P06401 PRGR_HUMAN 673 933 SEQADV 3G8O GLY A 671 UNP P06401 EXPRESSION TAG SEQADV 3G8O SER A 672 UNP P06401 EXPRESSION TAG SEQADV 3G8O GLY B 671 UNP P06401 EXPRESSION TAG SEQADV 3G8O SER B 672 UNP P06401 EXPRESSION TAG SEQRES 1 A 263 GLY SER PHE THR PHE SER PRO GLY GLN ASP ILE GLN LEU SEQRES 2 A 263 ILE PRO PRO LEU ILE ASN LEU LEU MET SER ILE GLU PRO SEQRES 3 A 263 ASP VAL ILE TYR ALA GLY HIS ASP ASN THR LYS PRO ASP SEQRES 4 A 263 THR SER SER SER LEU LEU THR SER LEU ASN GLN LEU GLY SEQRES 5 A 263 GLU ARG GLN LEU LEU SER VAL VAL LYS TRP SER LYS SER SEQRES 6 A 263 LEU PRO GLY PHE ARG ASN LEU HIS ILE ASP ASP GLN ILE SEQRES 7 A 263 THR LEU ILE GLN TYR SER TRP MET SER LEU MET VAL PHE SEQRES 8 A 263 GLY LEU GLY TRP ARG SER TYR LYS HIS VAL SER GLY GLN SEQRES 9 A 263 MET LEU TYR PHE ALA PRO ASP LEU ILE LEU ASN GLU GLN SEQRES 10 A 263 ARG MET LYS GLU SER SER PHE TYR SER LEU CYS LEU THR SEQRES 11 A 263 MET TRP GLN ILE PRO GLN GLU PHE VAL LYS LEU GLN VAL SEQRES 12 A 263 SER GLN GLU GLU PHE LEU CYS MET LYS VAL LEU LEU LEU SEQRES 13 A 263 LEU ASN THR ILE PRO LEU GLU GLY LEU ARG SER GLN THR SEQRES 14 A 263 GLN PHE GLU GLU MET ARG SER SER TYR ILE ARG GLU LEU SEQRES 15 A 263 ILE LYS ALA ILE GLY LEU ARG GLN LYS GLY VAL VAL SER SEQRES 16 A 263 SER SER GLN ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SEQRES 17 A 263 ASN LEU HIS ASP LEU VAL LYS GLN LEU HIS LEU TYR CYS SEQRES 18 A 263 LEU ASN THR PHE ILE GLN SER ARG ALA LEU SER VAL GLU SEQRES 19 A 263 PHE PRO GLU MET MET SER GLU VAL ILE ALA ALA GLN LEU SEQRES 20 A 263 PRO LYS ILE LEU ALA GLY MET VAL LYS PRO LEU LEU PHE SEQRES 21 A 263 HIS LYS LYS SEQRES 1 B 263 GLY SER PHE THR PHE SER PRO GLY GLN ASP ILE GLN LEU SEQRES 2 B 263 ILE PRO PRO LEU ILE ASN LEU LEU MET SER ILE GLU PRO SEQRES 3 B 263 ASP VAL ILE TYR ALA GLY HIS ASP ASN THR LYS PRO ASP SEQRES 4 B 263 THR SER SER SER LEU LEU THR SER LEU ASN GLN LEU GLY SEQRES 5 B 263 GLU ARG GLN LEU LEU SER VAL VAL LYS TRP SER LYS SER SEQRES 6 B 263 LEU PRO GLY PHE ARG ASN LEU HIS ILE ASP ASP GLN ILE SEQRES 7 B 263 THR LEU ILE GLN TYR SER TRP MET SER LEU MET VAL PHE SEQRES 8 B 263 GLY LEU GLY TRP ARG SER TYR LYS HIS VAL SER GLY GLN SEQRES 9 B 263 MET LEU TYR PHE ALA PRO ASP LEU ILE LEU ASN GLU GLN SEQRES 10 B 263 ARG MET LYS GLU SER SER PHE TYR SER LEU CYS LEU THR SEQRES 11 B 263 MET TRP GLN ILE PRO GLN GLU PHE VAL LYS LEU GLN VAL SEQRES 12 B 263 SER GLN GLU GLU PHE LEU CYS MET LYS VAL LEU LEU LEU SEQRES 13 B 263 LEU ASN THR ILE PRO LEU GLU GLY LEU ARG SER GLN THR SEQRES 14 B 263 GLN PHE GLU GLU MET ARG SER SER TYR ILE ARG GLU LEU SEQRES 15 B 263 ILE LYS ALA ILE GLY LEU ARG GLN LYS GLY VAL VAL SER SEQRES 16 B 263 SER SER GLN ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SEQRES 17 B 263 ASN LEU HIS ASP LEU VAL LYS GLN LEU HIS LEU TYR CYS SEQRES 18 B 263 LEU ASN THR PHE ILE GLN SER ARG ALA LEU SER VAL GLU SEQRES 19 B 263 PHE PRO GLU MET MET SER GLU VAL ILE ALA ALA GLN LEU SEQRES 20 B 263 PRO LYS ILE LEU ALA GLY MET VAL LYS PRO LEU LEU PHE SEQRES 21 B 263 HIS LYS LYS HET 30X A 1 25 HET 30X B 2 25 HET SO4 B 1 5 HETNAM 30X N~2~-[4-CYANO-3-(TRIFLUOROMETHYL)PHENYL]-N,N-DIMETHYL- HETNAM 2 30X N~2~-(2,2,2-TRIFLUOROETHYL)-L-ALANINAMIDE HETNAM SO4 SULFATE ION FORMUL 3 30X 2(C15 H15 F6 N3 O) FORMUL 5 SO4 O4 S 2- FORMUL 6 HOH *352(H2 O) HELIX 1 1 PRO A 685 ILE A 694 1 10 HELIX 2 2 THR A 710 LYS A 734 1 25 HELIX 3 3 GLY A 738 LEU A 742 5 5 HELIX 4 4 HIS A 743 SER A 772 1 30 HELIX 5 5 GLU A 791 TRP A 802 1 12 HELIX 6 6 TRP A 802 GLN A 812 1 11 HELIX 7 7 SER A 814 LEU A 827 1 14 HELIX 8 8 SER A 837 GLN A 860 1 24 HELIX 9 9 GLY A 862 GLN A 897 1 36 HELIX 10 10 GLN A 897 SER A 902 1 6 HELIX 11 11 PRO A 906 ALA A 922 1 17 HELIX 12 12 PRO B 685 ILE B 694 1 10 HELIX 13 13 THR B 710 LEU B 736 1 27 HELIX 14 14 GLY B 738 LEU B 742 5 5 HELIX 15 15 HIS B 743 VAL B 771 1 29 HELIX 16 16 ASN B 785 SER B 792 1 8 HELIX 17 17 PHE B 794 GLN B 812 1 19 HELIX 18 18 SER B 814 LEU B 827 1 14 HELIX 19 19 SER B 837 LEU B 858 1 22 HELIX 20 20 GLY B 862 GLN B 897 1 36 HELIX 21 21 GLN B 897 SER B 902 1 6 HELIX 22 22 PRO B 906 ALA B 922 1 17 SHEET 1 A 2 LEU A 776 ALA A 779 0 SHEET 2 A 2 LEU A 782 LEU A 784 -1 O LEU A 784 N LEU A 776 SHEET 1 B 2 THR A 829 PRO A 831 0 SHEET 2 B 2 VAL A 925 PRO A 927 -1 O LYS A 926 N ILE A 830 SHEET 1 C 2 LEU B 776 ALA B 779 0 SHEET 2 C 2 LEU B 782 LEU B 784 -1 O LEU B 784 N LEU B 776 SHEET 1 D 2 THR B 829 ILE B 830 0 SHEET 2 D 2 LYS B 926 PRO B 927 -1 O LYS B 926 N ILE B 830 SITE 1 AC1 15 LEU A 718 ASN A 719 LEU A 721 TRP A 755 SITE 2 AC1 15 MET A 759 VAL A 760 LEU A 763 ARG A 766 SITE 3 AC1 15 LEU A 797 MET A 801 LEU A 887 TYR A 890 SITE 4 AC1 15 CYS A 891 THR A 894 PHE A 905 SITE 1 AC2 15 LEU B 715 LEU B 718 ASN B 719 MET B 759 SITE 2 AC2 15 VAL B 760 LEU B 763 ARG B 766 PHE B 778 SITE 3 AC2 15 LEU B 797 LEU B 887 TYR B 890 CYS B 891 SITE 4 AC2 15 THR B 894 PHE B 905 MET B 909 CRYST1 57.670 64.208 70.500 90.00 96.01 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017340 0.000000 0.001826 0.00000 SCALE2 0.000000 0.015574 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014263 0.00000